These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22610240)

  • 1. DOCKing innate to adaptive signaling for persistent antibody production.
    Werner M; Jumaa H
    Nat Immunol; 2012 May; 13(6):525-6. PubMed ID: 22610240
    [No Abstract]   [Full Text] [Related]  

  • 2. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.
    Jabara HH; McDonald DR; Janssen E; Massaad MJ; Ramesh N; Borzutzky A; Rauter I; Benson H; Schneider L; Baxi S; Recher M; Notarangelo LD; Wakim R; Dbaibo G; Dasouki M; Al-Herz W; Barlan I; Baris S; Kutukculer N; Ochs HD; Plebani A; Kanariou M; Lefranc G; Reisli I; Fitzgerald KA; Golenbock D; Manis J; Keles S; Ceja R; Chatila TA; Geha RS
    Nat Immunol; 2012 May; 13(6):612-20. PubMed ID: 22581261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOCK8 and STAT3 dependent inhibition of IgE isotype switching by TLR9 ligation in human B cells.
    Massaad MJ; Cangemi B; Al-Herz W; LeFranc G; Freeman A; Baxi S; Keles S; Metin A; Dasouki M; Sobh A; Kanariou M; Al-Sukaiti N; Ozen A; Ochs H; Chatila TA; Manis JP; Geha R
    Clin Immunol; 2017 Oct; 183():263-265. PubMed ID: 28882618
    [No Abstract]   [Full Text] [Related]  

  • 4. IL-21 enhances the activity of the TLR-MyD88-STAT3 pathway but not the classical TLR-MyD88-NF-κB pathway in human B cells to boost antibody production.
    Liu BS; Stoop JN; Huizinga TW; Toes RE
    J Immunol; 2013 Oct; 191(8):4086-94. PubMed ID: 24043893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer.
    Rogers GL; Suzuki M; Zolotukhin I; Markusic DM; Morel LM; Lee B; Ertl HC; Herzog RW
    J Innate Immun; 2015; 7(3):302-14. PubMed ID: 25612611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation.
    Quintana FJ; Solomon A; Cohen IR; Nussbaum G
    PLoS One; 2008; 3(10):e3509. PubMed ID: 18946502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanine nucleotide exchange factor RABGEF1 regulates keratinocyte-intrinsic signaling to maintain skin homeostasis.
    Marichal T; Gaudenzio N; El Abbas S; Sibilano R; Zurek O; Starkl P; Reber LL; Pirottin D; Kim J; Chambon P; Roers A; Antoine N; Kawakami Y; Kawakami T; Bureau F; Tam SY; Tsai M; Galli SJ
    J Clin Invest; 2016 Dec; 126(12):4497-4515. PubMed ID: 27820702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors in multiple sclerosis mouse experimental models.
    Marta M
    Ann N Y Acad Sci; 2009 Sep; 1173():458-62. PubMed ID: 19758186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.
    Capolunghi F; Rosado MM; Cascioli S; Girolami E; Bordasco S; Vivarelli M; Ruggiero B; Cortis E; Insalaco A; Fantò N; Gallo G; Nucera E; Loiarro M; Sette C; De Santis R; Carsetti R; Ruggiero V
    Rheumatology (Oxford); 2010 Dec; 49(12):2281-9. PubMed ID: 20739362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T
    Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response.
    Hou B; Saudan P; Ott G; Wheeler ML; Ji M; Kuzmich L; Lee LM; Coffman RL; Bachmann MF; DeFranco AL
    Immunity; 2011 Mar; 34(3):375-84. PubMed ID: 21353603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells.
    Schmitz F; Heit A; Guggemoos S; Krug A; Mages J; Schiemann M; Adler H; Drexler I; Haas T; Lang R; Wagner H
    Eur J Immunol; 2007 Feb; 37(2):315-27. PubMed ID: 17273999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c
    Yim LY; Lau CS; Chan VS
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
    Derkow K; Krüger C; Dembny P; Lehnardt S
    PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.
    Dai P; Cao H; Merghoub T; Avogadri F; Wang W; Parikh T; Fang CM; Pitha PM; Fitzgerald KA; Rahman MM; McFadden G; Hu X; Houghton AN; Shuman S; Deng L
    J Virol; 2011 Oct; 85(20):10814-25. PubMed ID: 21835795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.
    Oliveira AC; de Alencar BC; Tzelepis F; Klezewsky W; da Silva RN; Neves FS; Cavalcanti GS; Boscardin S; Nunes MP; Santiago MF; Nóbrega A; Rodrigues MM; Bellio M
    PLoS Pathog; 2010 Apr; 6(4):e1000870. PubMed ID: 20442858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.
    Cervantes-Barragán L; Gil-Cruz C; Pastelin-Palacios R; Lang KS; Isibasi A; Ludewig B; López-Macías C
    Eur J Immunol; 2009 Jan; 39(1):126-35. PubMed ID: 19130558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.
    Nickerson KM; Christensen SR; Shupe J; Kashgarian M; Kim D; Elkon K; Shlomchik MJ
    J Immunol; 2010 Feb; 184(4):1840-8. PubMed ID: 20089701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy.
    Kortylewski M; Kujawski M; Herrmann A; Yang C; Wang L; Liu Y; Salcedo R; Yu H
    Cancer Res; 2009 Mar; 69(6):2497-505. PubMed ID: 19258507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exposure to methamphetamine alters TLR9-mediated cytokine expression in human macrophage.
    Burns A; Ciborowski P
    Immunobiology; 2016 Feb; 221(2):199-207. PubMed ID: 26387832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.